Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

BTE vs CVE: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CVE Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 9–1 Matrix Metrics)

CVE Overall Winner 6-Pillar Tally: BTE 2 – 3 CVE (1 Tie) Matrix Metrics: BTE 1 – 9 CVE

As of Nov 16, 2026, Cenovus Energy Inc. (CVE) is the stronger overall head-to-head candidate over Baytex Energy Corp. (BTE) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). BTE carries a Unified Composite Score of 63.4/100 (BUY) at $4.18 (17.5x Forward P/E, 11.7% operating margin), whereas CVE carries 64.3/100 (BUY) at $28.23 (8.2x Forward P/E, 20.7% operating margin).

  • Technical & Structure Timing Caution: BTE trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 32.8); meanwhile CVE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BTE vs CVE
BTE NYSE
Baytex Energy Corp.
Drilling Oil & Gas Wells
$4.18
-3.79% 1D
Market Cap $2.9B
TTM Revenue $1.80B
Forward P/E 17.5x
Beta / 30D Vol -0.34β · 53% Vol
Unified Composite Score
63.4 / 100 BUY
Tech 63.0 Fund 58.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 33
RSI-14: 32.8 · SMA20: $4.83 · SMA50: $4.83
CVE NYSE Head-to-Head Winner
Cenovus Energy Inc.
Crude Petroleum & Natural Gas
$28.23
-2.92% 1D
Market Cap $52.2B
TTM Revenue $39.7B
Forward P/E 8.2x
Beta / 30D Vol -0.46β · 45% Vol
Unified Composite Score
64.3 / 100 BUY
Tech 74.0 Fund 62.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -1.7%), weak momentum, RSI 38
RSI-14: 38.4 · SMA20: $30.40 · SMA50: $31.43

6-Pillar Scorecard Institutional Category Breakdown (BTE 2 – 3 CVE)

Columns: Metric · BTE · CVE
1. Valuation Multiples CVE
Forward P/E 17.5x 8.2x
Trailing P/E 17.5x 8.5x
PEG Ratio N/M 0.45x
EV / Revenue 1.6x 1.3x
2. Growth & Scale BTE
Revenue Growth (YoY) +33.1% +21.1%
Earnings Growth (YoY) +503.0% +155.0%
TTM Revenue (USD) $1.80B $39.7B
Market Cap $2.9B $52.2B
3. Profitability & Quality CVE
Gross Margin 61.7% 33.9%
Operating Margin 11.7% 20.7%
Net Profit Margin -32.7% 15.4%
Return on Equity (ROE) -2.7% 27.4%
4. Balance Sheet & Cash Flow CVE
Cash Generation (TTM) $865M EBITDA $12.1B EBITDA
Cash Flow Margin 48.0% EBITDA Mgn 30.4% EBITDA Mgn
Net Cash / Leverage $2.23 Book/Sh · -2.7% ROE $13.89 Book/Sh · 27.4% ROE
Dividend Yield 2.11% 2.96%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 57.6% (73rd %ile) 27.6% (59th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat BTE
OpEx & R&D Intensity 50.0% of Rev ($900M) 13.2% of Rev ($5.24B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Scale & Operating Efficiency Moat
Supply-Chain Role Oil & Gas E&P Operator Oil & Gas Integrated Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BTE (1) vs CVE (9)
Institutional Metric BTE CVE Criterion Row Edge
Market Capitalization
Scale
$2.9B $52.2B Larger Scale CVE
Trailing P/E Ratio
Valuation
17.5x 8.5x Lower Multiple CVE
Forward P/E Ratio
Valuation
17.5x 8.2x Lower Multiple CVE
Revenue Growth (YoY)
Growth
+33.1% +21.1% Higher Growth BTE
Operating Margin (TTM)
Profitability
11.7% 20.7% Higher Margin CVE
Net Profit Margin
Profitability
-32.7% 15.4% Higher Margin CVE
Return on Equity (ROE)
Capital Efficiency
-2.7% 27.4% Higher ROE CVE
52-Week Range Position
Momentum
46% ($3–$6) 68% ($16–$34) Stronger Trend CVE
Beta / 30D Volatility
Risk Regime
-0.34β · 53% Vol -0.46β · 45% Vol Lower Realized Risk CVE
Unified Institutional Score
Composite Signal
63.4 / 100 (BUY) 64.3 / 100 (BUY) Higher Composite CVE
Trailing 12M Revenue (USD)
Operating Scale
$1.80B $39.7B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
61.7% 33.9% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 1.6x EV/Rev 0.45x PEG · 1.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$865M EBITDA ($2.23 Book/Sh · -2.7% ROE) $12.1B EBITDA ($13.89 Book/Sh · 27.4% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CVE +6.89 pp
BTE: -21.19% · CVE: -14.3%
3M Horizon BTE +2.61 pp
BTE: -10.58% · CVE: -13.19%
6M Horizon CVE +10.31 pp
BTE: -20.89% · CVE: -10.58%
1Y Horizon CVE +25.05 pp
BTE: +33.28% · CVE: +58.33%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BTE vs CVE. Trailing 12-month operating profitability (BTE 11.7% vs CVE 20.7%) and valuation multiples (BTE 17.5x vs CVE 8.2x Forward P/E) are benchmarked directly in Pillar 4 below.

BTE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.80B
Gross Margin61.7%
Op. Margin11.7%
ROE / Fwd P/E-2.7% · 17.5x
CVE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$39.7B
Gross Margin33.9%
Op. Margin20.7%
ROE / Fwd P/E27.4% · 8.2x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BTE UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 57.6%
IV Percentile 73rd %ile
Put/Call OI Skew N/A
IV Regime Elevated (60th–80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BTE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CVE UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 27.6%
IV Percentile 59th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CVE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BTE Moat Profile Cyclical / Execution-Driven Positioning
Oil & Gas E&P Operator
Competes within the Oil & Gas E&P value chain with $2.9B market capitalization and 11.7% operating margin.
OpEx & R&D Reinvestment 50.0% of Rev ($900M)
90D Engineering Disclosures 0 Published
CVE Moat Profile Scale & Operating Efficiency Moat
Oil & Gas Integrated Operator
Competes within the Oil & Gas Integrated value chain with $52.2B market capitalization and 20.7% operating margin.
OpEx & R&D Reinvestment 13.2% of Rev ($5.24B)
90D Engineering Disclosures 0 Published

Investor FAQ BTE vs CVE Key Questions & Quantitative Answers

As of Nov 16, 2026, Cenovus Energy Inc. (CVE) is the stronger overall head-to-head candidate over Baytex Energy Corp. (BTE) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). BTE carries a Unified Composite Score of 63.4/100 (BUY) at $4.18 (17.5x Forward P/E, 11.7% operating margin), whereas CVE carries 64.3/100 (BUY) at $28.23 (8.2x Forward P/E, 20.7% operating margin). Technical & Structure Timing Caution: BTE trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 32.8); meanwhile CVE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

BTE leads the Growth & Scale pillar: BTE posts +33.1% YoY revenue growth and +503.0% YoY earnings growth on $1.80B TTM revenue (61.7% gross margin, 11.7% operating margin), compared with CVE at +21.1% YoY revenue growth and +155.0% YoY earnings growth on $39.7B TTM revenue (33.9% gross margin, 20.7% operating margin). On trailing 12-month operating scale, BTE generates $1.80B in USD-normalized revenue versus $39.7B for CVE. In operating R&D and SG&A reinvestment, BTE deploys 50.0% of Rev ($900M) (0 90-day corporate R&D disclosures) versus 13.2% of Rev ($5.24B) (0 disclosures) for CVE.

CVE screens cheaper on headline valuation multiples. BTE trades at 17.5x Forward P/E, 17.5x Trailing P/E, N/M PEG, and 1.6x EV/Revenue (48.0% EBITDA margin), whereas CVE trades at 8.2x Forward P/E, 8.5x Trailing P/E, 0.45x PEG, and 1.3x EV/Revenue (30.4% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BTE (-2.7% ROE) versus CVE (27.4% ROE) capital efficiency.

In options market volatility and institutional positioning, BTE carries 57.6% implied volatility (73rd %ile, Elevated (60th–80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.34β · 53% Vol realized risk). By comparison, CVE carries 27.6% implied volatility (59th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.46β · 45% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.